Yasmin S Hamirani1, Ronit Katz2, Khurram Nasir3, Irfan Zeb4, Michael J Blaha5, Roger S Blumenthal6, Richard N Kronmal2, Matthew J Budoff7. 1. Cardiovascular Imaging Fellow, Los Angeles Biomedical Research Institute at Harbor-UCLA Ronit Katz, DPhil. 2. University of Washington, Seattle, WA. 3. Adjunct Assistant Professor of Medicine, Ciccarone Center for Preventive Cardiology, Johns Hopkins University, Baltimore, MD. 4. Resident in Internal Medicine. 5. Assistant Professor of Medicine, Ciccarone Center for Preventive Cardiology, Johns Hopkins University, Baltimore, MD. 6. Professor of Medicine, Ciccarone Centre of Preventive Cardiology, Johns Hopkins University, Baltimore, MD. 7. Professor of Medicine, Los Angeles Biomedical Research Institute at Harbor-ULCA, Torrance, CA.
Abstract
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a common liver disease. Data is emerging that an independent association between markers of subclinical atherosclerosis and NAFLD exists and it may be considered as an independent predictor of cardiovascular (CV) outcomes. We aim to better characterize the relationship between NAFLD and inflammatory markers in a multi-ethnic cohort by assessing fatty liver on computed tomography (CT) scans. METHODS: The Multi-Ethnic Study of Atherosclerosis (MESA) is a longitudinal, population-based study from four ethnic groups free of CV disease at baseline. The inflammatory markers studied include: C-reactive protein (CRP) and interleukin 6 (IL-6). On CT scans liver-to-spleen ratio (LSR: Hounsfield Units (HU) of the liver divided by HU of spleen) of <1 and liver attenuation of <40 HU were used as criteria for fatty liver. Unadjusted and adjusted multivariate linear and logistic regression analysis was performed. RESULTS: 4038 participants amongst 6814 MESA population with visible spleen on the CT scan, available CRP and IL-6 levels and no reported liver cirrhosis were included. The average age was 61 +/- 10 years, 37% Caucasians and 45% were males. Mean CRP and IL-6 were 2.36 mg/dl and 1.37 pg/ml respectively. 696 participants (17%) had LSR of <1 and 253 (6%) had liver attenuation of <40 HU. When using LSR <1 as a continuous variable, the correlation (adjusted odds ratio (OR)) with CRP >2.0 was 0.037 (95% CI: 0.02-0.054) and with IL-6 was 0.014 (95% CI: 0.004-0.023). On the other hand when presence and absence of LSR <1 was considered, higher ORs for association with CRP >2: 1.41 (95% CI: 1.16 to 1.73) and IL6:1.18 (95% CI: 1.05 to 1.31) were found. Similarly, the adjusted association of per unit decrease in liver attenuation with CRP>2 was 1.92 (95% CI: 1.20 to 2.63) while for IL-6 was 1.08 (95% CI: 0.69 to 1.47). When considering presence and absence of liver attenuation <40 HU the OR for CRP >2 was 2.27 (95% CI: 1.62 to 3.16) and for IL-6 was 1.33 (95% CI: 1.13 to 1.58). CONCLUSION: CRP and IL-6 levels were found to be significantly associated with liver fat assessed on CT scan after adjusting for other risk factors for atherosclerosis.
BACKGROUND:Nonalcoholic fatty liver disease (NAFLD) is a common liver disease. Data is emerging that an independent association between markers of subclinical atherosclerosis and NAFLD exists and it may be considered as an independent predictor of cardiovascular (CV) outcomes. We aim to better characterize the relationship between NAFLD and inflammatory markers in a multi-ethnic cohort by assessing fatty liver on computed tomography (CT) scans. METHODS: The Multi-Ethnic Study of Atherosclerosis (MESA) is a longitudinal, population-based study from four ethnic groups free of CV disease at baseline. The inflammatory markers studied include: C-reactive protein (CRP) and interleukin 6 (IL-6). On CT scans liver-to-spleen ratio (LSR: Hounsfield Units (HU) of the liver divided by HU of spleen) of <1 and liver attenuation of <40 HU were used as criteria for fatty liver. Unadjusted and adjusted multivariate linear and logistic regression analysis was performed. RESULTS: 4038 participants amongst 6814 MESA population with visible spleen on the CT scan, available CRP and IL-6 levels and no reported liver cirrhosis were included. The average age was 61 +/- 10 years, 37% Caucasians and 45% were males. Mean CRP and IL-6 were 2.36 mg/dl and 1.37 pg/ml respectively. 696 participants (17%) had LSR of <1 and 253 (6%) had liver attenuation of <40 HU. When using LSR <1 as a continuous variable, the correlation (adjusted odds ratio (OR)) with CRP >2.0 was 0.037 (95% CI: 0.02-0.054) and with IL-6 was 0.014 (95% CI: 0.004-0.023). On the other hand when presence and absence of LSR <1 was considered, higher ORs for association with CRP >2: 1.41 (95% CI: 1.16 to 1.73) and IL6:1.18 (95% CI: 1.05 to 1.31) were found. Similarly, the adjusted association of per unit decrease in liver attenuation with CRP>2 was 1.92 (95% CI: 1.20 to 2.63) while for IL-6 was 1.08 (95% CI: 0.69 to 1.47). When considering presence and absence of liver attenuation <40 HU the OR for CRP >2 was 2.27 (95% CI: 1.62 to 3.16) and for IL-6 was 1.33 (95% CI: 1.13 to 1.58). CONCLUSION:CRP and IL-6 levels were found to be significantly associated with liver fat assessed on CT scan after adjusting for other risk factors for atherosclerosis.
Authors: Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs Journal: Circulation Date: 2010-11-15 Impact factor: 29.690
Authors: Raul D Santos; Khurram Nasir; Raquel D Conceição; Ammar Sarwar; Jose A M Carvalho; Roger S Blumenthal Journal: Atherosclerosis Date: 2007-03-01 Impact factor: 5.162
Authors: Susan Matulevicius; Laura C Huff; Lidia S Szczepaniak; Colby R Ayers; Matthew Budoff; Roderick McColl; Amit Khera; Ronald M Peshock Journal: J Investig Med Date: 2011-06 Impact factor: 2.895
Authors: Lucia Pacifico; Vito Cantisani; Paolo Ricci; John F Osborn; Elisa Schiavo; Caterina Anania; Eva Ferrara; Giuliano Dvisic; Claudio Chiesa Journal: Pediatr Res Date: 2008-04 Impact factor: 3.756
Authors: Otto A Sanchez; Mariana Lazo-Elizondo; Irfan Zeb; Russell P Tracy; Ryan Bradley; Daniel A Duprez; Hossein Bahrami; Carmen A Peralta; Lori B Daniels; João A Lima; Alan Maisel; David R Jacobs; Mathew J Budoff Journal: Metabolism Date: 2016-02-27 Impact factor: 8.694
Authors: Zachary P Fricker; Alison Pedley; Joseph M Massaro; Ramachandran S Vasan; Udo Hoffmann; Emelia J Benjamin; Michelle T Long Journal: Clin Gastroenterol Hepatol Date: 2018-11-23 Impact factor: 11.382
Authors: Fatjon Leti; Christophe Legendre; Christopher D Still; Xin Chu; Anthony Petrick; Glenn S Gerhard; Johanna K DiStefano Journal: Transl Res Date: 2017-09-19 Impact factor: 7.012
Authors: Anita Rajamani; Kamil Borkowski; Samir Akre; Andrea Fernandez; John W Newman; Scott I Simon; Anthony G Passerini Journal: Sci Rep Date: 2019-06-17 Impact factor: 4.379
Authors: Ehimen C Aneni; Marcio Sommer Bittencourt; Catherine Teng; Miguel Cainzos-Achirica; Chukwuemeka U Osondu; Ahmed Soliman; Mouaz Al-Mallah; Matthew Buddoff; Edison R Parise; Raul D Santos; Khurram Nasir Journal: Am J Prev Cardiol Date: 2020-10-20